Related Experiment Video
Updated: Feb 7, 2026

Production of Recombinant PRMT Proteins using the Baculovirus Expression Vector System
Published on: July 17, 2021
Production of biologically active feline interferon beta in insect larvae using a recombinant baculovirus
Mariana Bernadett Arregui1,2, Gregorio Juan Mc Callum1,2, Ignacio Smith1,2
11Facultad de Farmacia y Bioquímica, Cátedra de Biotecnología, Universidad de Buenos Aires, Junín 956, 1113 Buenos Aires, Argentina.
Insights
Researchers developed a cost-effective method to produce recombinant feline interferon beta (rFeIFNβ) in insect larvae. This scalable production yields biologically active rFeIFNβ for research and veterinary applications.
Area of Science:
- Biotechnology
- Immunology
- Virology
Background:
- Feline interferon beta (FeIFNβ) is a type I cytokine with antitumor, antiviral, and immunomodulatory properties.
- Efficient production of FeIFNβ is crucial for research and veterinary applications.
Purpose of the Study:
- To establish a cost-effective platform for large-scale production of recombinant feline interferon beta (rFeIFNβ).
- To characterize the biological activity and glycosylation of the produced rFeIFNβ.
Main Methods:
- Recombinant feline interferon beta (rFeIFNβ) was expressed in *Spodoptera frugiperda* insect larvae using a recombinant baculovirus system.
- Purification was performed using Blue-Sepharose chromatography from larval hemolymph.
- Biological activity was assessed through in vitro antiviral and antitumor assays.
- Glycosylation was confirmed via peptide-N-glycosidase F digestion.
Main Results:
- Purified rFeIFNβ exhibited a specific activity of 1 × 106 IU mg-1.
- A yield of 8.9 × 104 IU of rFeIFNβ per larva was achieved.
- The rFeIFNβ demonstrated potent in vitro antiviral activity (9.5 × 104 IU mL-1) and antitumor activity comparable to commercial FeIFNω.
- Glycosylation of rFeIFNβ was confirmed.
Conclusions:
- A cost-effective and scalable platform for producing biologically active rFeIFNβ in insect larvae was successfully developed.
- This method provides a valuable resource for laboratory research and veterinary medicine applications requiring feline interferon beta.
Abstract:
Feline interferon beta is a cytokine that belongs to the type I IFN family, with antitumor, antiviral and immunomodulatory functions. In this work, recombinant feline interferon beta (rFeIFNβ) was expressed in insect larvae that constitute important agronomic plagues. rFeIFNβ accumulated in the hemolymph of Spodoptera frugiperda larvae infected with recombinant baculovirus and was purified by Blue-Sepharose chromatography directly from larval homogenates on day 4 post-infection. rFeIFNβ was recovered after purification with a specific activity of 1 × 106 IU mg-1. By this method, we obtained 8.9 × 104 IU of purified rFeIFNβ per larva. The product was biologically active in vitro, with an antiviral activity of 9.5 × 104 IU mL-1, as well as a potent antitumor activity comparable to that of the commercial FeIFNω. The glycosylation of rFeIFNβ was confirmed by peptide-N-glycosidase F digestion. Our findings provide a cost-effective platform for large-scale rFeIFNβ production in laboratory research or veterinary medicine applications.
More Related Videos
Related Concept Videos
Osmoregulation in Insects
What is Conservation Biology?
Drug Products: Biologics, Biosimilars and Interchangeables
Biological Effects of Radiation
Recombinant DNA
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...

